Finance

Lists
524715:BOM
Sun Pharmaceutical Industries Ltd
₹ १,७६०.००
-०.०३%
(-०.६०) 1D
अक्टोबर १६, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524715...
Open
₹ १,७५९.६०
High
₹ १,७६४.४०
Low
₹ १,७४४.८५
Mkt. cap
४२.२० खरब
Avg. vol.
९७.३७ हजार
Volume
३५.६८ हजार
Dividend
०.९१%
Quarterly dividend
₹ ४.००
Ex-dividend date
२०२६ जुलाई ७
P/E ratio
३४.८९
52-wk high
₹ २,०४७.५५
52-wk low
₹ १,५८३.६०
EPS
₹ ५०.४४
Shares outstanding
०.००
No. of employees
४७ हजार
Open
₹ १,७५९.६०
High
₹ १,७६४.४०
Low
₹ १,७४४.८५
Mkt. cap
४२.२० खरब
Avg. vol.
९७.३७ हजार
Volume
३५.६८ हजार
Dividend
०.९१%
Quarterly dividend
₹ ४.००
Ex-dividend date
२०२६ जुलाई ७
P/E ratio
३४.८९
52-wk high
₹ २,०४७.५५
52-wk low
₹ १,५८३.६०
EPS
₹ ५०.४४
Shares outstanding
०.००
No. of employees
४७ हजार
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
१ दिन पहिले
Sun Pharma stock: Results are due October 29 for Sun Pharma stock
ad-hoc-news.de
ad-hoc-news.de
·
२ दिन पहिले
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd
CEO-
Employees४७ हजार
Founded१९८३
HeadquartersGoregaon East, मुम्बई, भारत
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.४५ खरब
१.५५ खरब
१.४६ खरब
१.५३ खरब
Cost of goods sold
२९.८३ अरब
२९.४५ अरब
३७.३६ अरब
२९.६३ अरब
Cost of revenue
२९.८३ अरब
२९.४५ अरब
३७.३६ अरब
२९.६३ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२७.६५ अरब
२८.९२ अरब
३०.६० अरब
३२.२७ अरब
Operating expense
८१.२८ अरब
८५.१३ अरब
८०.६६ अरब
८७.८० अरब
Total operating expenses
१.११ खरब
१.१५ खरब
१.१८ खरब
१.१७ खरब
Operating income
३३.६७ अरब
४०.६२ अरब
२८.१० अरब
३५.५७ अरब
Other non operating income
४.७० अरब
५.७९ अरब
-१४.२९ अरब
७.२४ अरब
EBT including unusual items
४१.५५ अरब
४२.०७ अरब
३५.३७ अरब
४०.८९ अरब
EBT excluding unusual items
४१.५५ अरब
४६.९७ अरब
२६.८३ अरब
४२.९३ अरब
Income tax expense
१०.३१ अरब
८.२६ अरब
८.२८ अरब
११.८८ अरब
Effective tax rate
२४.८०%
१९.६३%
२३.४०%
२९.०५%
Other operating expenses
४६.३४ अरब
४८.८९ अरब
४२.३० अरब
४८.१४ अरब
Net income
३१.१८ अरब
३३.६९ अरब
२७.१४ अरब
२८.९५ अरब
Net profit margin
२१.५४%
२१.७१%
१८.५७%
१८.९२%
Earnings per share
१३.००
१५.४८
११.३०
१२.७१
Interest and investment income
-
-
९.७४ अरब
-
Interest expense
-९९.८६ करोड
-७८.३६ करोड
-८५.८९ करोड
-९९.६७ करोड
Net interest expenses
-९९.८६ करोड
-७८.३६ करोड
८.८९ अरब
-९९.६७ करोड
Depreciation and amortization charges
७.३० अरब
७.३२ अरब
७.७५ अरब
७.३९ अरब
EBITDA
४०.८२ अरब
४६.५३ अरब
३४.८६ अरब
४२.३२ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू